期刊文献+

FⅤ Leiden突变与缺血性卒中 被引量:2

Factor Ⅴ Leiden Mutation and Ischemic Stroke
暂未订购
导出
摘要 F Ⅴ Leiden突变可导致活化蛋白C抵抗现象,是引起白种人静脉血栓栓塞的最常见遗传因素。但对这一突变与缺血性卒中的关系尚存有争议。文章综述了F Ⅴ Leiden突变的分子机制及近年来在缺血性卒中方面的研究情况。 Factor Ⅴ Leiden mutation can cause the phenomenon of activated protein C resistance. It is the most common genetic factor for venous thromboembolism in the white population. However, the relationship between factor Ⅴ Leiden mutation and ischemic stroke remains controversial. The article reviews the molecular mechanism of factor Ⅴ Leiden mutation and the recent findings in ischemic stroke.
出处 《国外医学(脑血管疾病分册)》 2004年第3期231-233,共3页 Foreign Medical Sciences Cerebrovascular Diseases
关键词 FⅤ LEIDEN突变 缺血性卒中 活化蛋白C抵抗 分子机制 抗凝功能 factor Ⅴ Leiden mutation activated protein C resistance ischemic stroke molecular mechanism
  • 相关文献

参考文献44

  • 1Dahlback B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofaetor to activated protein C. Proc Natl Acad Sci USA, 1993, 90:1004 -1008.
  • 2Bertina RM, Koeleman BP, Koster T, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature, 1994, 369:64 - 67.
  • 3Lee R. Factor V Leiden: a clinical review. Am J Med Sci, 2001,322:88 - 102.
  • 4Dahlback B. Procoagulant and anticoagulant properties of coagulation factor V: factor V Leiden (APC resistance) causes hypercoagulabilitv by dual mechanisms. J Lab Clin Med, 1999, 133:415 -422.
  • 5Kane WH. Davie EW. Blood coaguhtion factors Ⅴ and Ⅷ: structural and functional sknilarities and thek relationship to hemorrhagic and thrombotic disorders. Blood, 1988, 71:539 -555.
  • 6Nicolaes GA, Tans G, Thomassen MC, et al. Peptide bond cleavages and loss of functional activity during inactivation of factor Ⅴa and factor VaR506Q by activated protein C. J Biol Chem, 1995, 270:21158 -21166.
  • 7Kalafatis M, Rand MD, Mann KG. The mechanism of inactivation of human factor V and human factor Va by activated protein C. J Biol Chem, 1994, 269:31869 -31880.
  • 8Arnljots B, Bergqvist D, Dahlback B. Inhibition of mieroarterial thrombosis by activated protein C in a rabbit model. Thromb Hhenaost, 1994, 72:415 -420.
  • 9Lindqvist PG, Svensson PJ, Dahgaack B, et ak Factor V Q506 mutation (activated protein C resistance) associated with reduced intrapartum blood loss-a possible evolutionary selection mechanism.Thromb Haemost, 1998, 79:69 - 73.
  • 10de Visser MC, Rosendaal FR, Bertina RM. A reduced sensitivity for activated protein C in the absence of factorV Leiden increases the risk of venous thrombosis. Blood, 1999, 93:1271 - 1276.

同被引文献16

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部